Abstract
Purpose
Due to the well-known intradialytic haemoglobin (Hb) change, it has been suggested that true functional Hb differs from pre-dialysis Hb. However, mechanisms of this change are not understood properly. We aimed at studying the role of plasma volume variation.
Methods
This is a multicentre study with two consecutive phases. First, true functional Hb was predicted by Krisper’s formula that estimates time-averaged haemoglobin concentration (TAC-Hb) and by the average (Avg-Hb) of Pre-Hb and Post-Hb (n = 346). Erythropoiesis-stimulating agent (ESA) doses were estimated according to the FDA instructions. Second, we investigated the correlations between Hb changes (ΔHb), body weight loss (ΔBW) and relative plasma volume changes (%ΔPV) in subjects with a weight gain higher than 1 kg (n = 208).
Results
First: Avg-Hb and TAC-Hb were similar to each other and higher than midweek Pre-Hb (p < 0. 002). Odds of having an Hb change >1 g/dL were 0.415. Odds were similar in both women and men [odds ratio (OR) 0.923; 95 % confidence interval (CI) 0.591–1.441]. If ESA doses were estimated by TAC-Hb or Avg-Hb instead of Pre-Hb, they should be lower in 40 % of the 346 patients. Second: Mean %ΔPV was −12.1 % (95 % CI −10.72/−13.48), and mean ΔHb was 1.1 g/dL (95 % CI 0.97/1.25). Correlation between ΔHb and %ΔPV was −0.92 (r 2 0.84) whereas that of ΔHb/ΔBW was just −0.45 (r 2 0.21; p < 0.000). Prevalence of ΔHb >1 g/dL was independent of ΔBW from 1.4 to 6.3 kg. By contrast, prevalence of ΔHb >1 g/dL in %ΔPV quartiles was clearly linear: 0, 52, 90 and 100 %, respectively.
Conclusions
Plasma volume variations play a major role in intradialytic Hb change. True functional Hb should be estimated in all patients with a weight gain higher than 1 kg.
Similar content being viewed by others
References
Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU et al (2009) A trial of darbepoetin alfa in type 2 diabetesand chronic kidney disease. N Engl J Med 361:2019–2032
Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM et al (1998) The effects of normal as compared with low hematocrit values inpatients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584–590
Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M et al (2006) Correction of anaemia with epoetin alpha in chronic kidney disease. N Engl J Med 355:2085–2098
Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anaemia. N Engl J Med 355:2071–2084
Unger EF, Thompson AM, Blank MJ, Temple R (2010) Erythropoiesis-stimulating agents, time for a reevaluation. N Engl J Med 362(3):189–192
Vlassopoulos D, Sonikian M, Dardioti V, Hadjiconstaninou V (1999) Target haematocrit during erythropoietin treatment in dialysis patients. Which value is ‘true-functional haematocrit’? Nephrol Dial Transplant 14:1340
Krisper P, Quehenberger F, Schneditz D, Holzer H, Polaschegg HD (2003) Prediction of time-averaged concentration of haemoglobin in haemodialysis patients. Nephrol Dial Transpl 18:2082–2087
Castillo et al (2012) Should we adjust erythropoiesis stimulating agent dosage to postdialysis hemoglobin levels? A pilot study. BMC Nephrol 13:60
Korzets A, Ori Y, Zevin D, Gafter U (2002) Posthemodialysis hemoglobin levels: overdue or not? Am J Kidney Dis 40(4):873
Bellizzi V, Minutolo R, Terracciano V et al (2002) Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients. Am J Kidney Dis 40:549–555
Geller A, DeVita M, Marku-Podvorica J, Rosenstock J, Panagopoulos G, Michelis M. Increase in post-dialysis hemoglobin can be out of proportion and unrelated to ultrafiltration. Dialysis & Transplantation 2010 (February: 1–4)
Minutolo R, De Nicola L, Bellizzi V (2003) Intra- and post-dialytic changes of haemoglobin concentrations in non-anaemic haemodialysis patients. Nephrol Dial Transpl 18:2606–2612
Daugirdas JT, Tattersall J (2010) Effect of treatment spacing and frequency on three measures of equivalent clearance, including standard Kt/V. Nephrol Dial Transpl 25(2):558–561
PROCRIT (epoetin alpha) [Nephrology prescribing information]. Amgen: Th Oaks, 2011 (http://www.procrit.com/sites/default/files/pdf/ProcritBooklet.pdf)
van Beaumont W (1972) Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol. 32(5):712–713
Koomans H, Geers A (1984) Dorhout Mees E. Plasma volume recovery after ultrafiltration in patients with chronic renal failure. Kidney Int 26:848–854
Bland J, Altman G (2003) Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 22:85–93
Sedgwick P (2012) What are odds? BMJ 344:e2853
Movilli E, Cancarini GC, Cassamali S, Camerini C, Brunori G, Maffei C, Maiorca R (2004) Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. Nephrol Dial Transplant 19:185–189
Movilli E, Pertica N, Camerini C et al (2002) Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy. Am J Kidney Dis 39:850–853
Siga E, Aiziczon D, Diaz G (2011) Optimizacion del tratamiento con hierro endovenoso en hemodiálisis. Estudio Clinico prospectivo a largo plazo. Medicina (Bs. As) 71:9–14
Conflict of interest
All authors state that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siga, E., Fernandez, M., Galarza, M. et al. Difference between true functional haemoglobin and pre-dialysis haemoglobin is associated with plasma volume variation: a multicentre study. Int Urol Nephrol 46, 2379–2384 (2014). https://doi.org/10.1007/s11255-014-0774-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0774-2